Project RD.06.SPR.202699 – A long-term study to assess the safety and efficacy of nemolizumab(CD14152) in subjects with…

Basic data

Acronym:
RD.06.SPR.202699
Title:
A long-term study to assess the safety and efficacy of nemolizumab(CD14152) in subjects with prurigo nodularis (PN)
Duration:
04/05/2020 to 31/12/2022
Abstract / short description:
A Prospective, Multicenter, Long-Term Study to Assess the Safety and
Efficacy of Nemolizumab (CD14152) in Subjects with Prurigo Nodularis
Keywords:
Pruigo nodularis

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

La Tour-de-Peilz, Switzerland
Help

will be deleted permanently. This cannot be undone.